BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9206048)

  • 21. Lymph node metastasis and surgical management of gastric cancer invading the esophagus.
    Yonemura Y; Tsugawa K; Fonseca L; Fushida S; Matsumoto H; Ninomiya I; Sugiyama K; Fujimura T; Nishimura G; Miwa K
    Hepatogastroenterology; 1995 Feb; 42(1):37-42. PubMed ID: 7782032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic significance of tumor size in the survival of patients with advanced gastric carcinoma].
    Díaz Plasencia JA; Yan-Quiroz EF; Burgos-Chávez OA; Santillán-Medina JP; Stewart-Vilela Guillén E; Rojas-Vergara AM
    Rev Gastroenterol Peru; 2001; 21(1):21-9. PubMed ID: 12170283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic differences of adenocarcinoma arising from the cardia and the upper third of the stomach.
    Nakane Y; Okamura S; Boku T; Okusa T; Tanaka K; Hioki K
    Am Surg; 1993 Jul; 59(7):423-9. PubMed ID: 8323075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic predictors of patients with carcinoma of the gastric cardia.
    Zhang M; Li Z; Ma Y; Zhu G; Zhang H; Xue Y
    Hepatogastroenterology; 2012 May; 59(115):930-3. PubMed ID: 22469742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection.
    Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T
    Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of survival period for patients with postoperative recurrence after curative resection for advanced gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Hepatogastroenterology; 2001; 48(37):290-3. PubMed ID: 11268988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of lymphovascular invasion in patients with stage I gastric cancer.
    Kunisaki C; Makino H; Kimura J; Takagawa R; Kosaka T; Ono HA; Akiyama H; Fukushima T; Nagahori Y; Takahashi M
    Surgery; 2010 Feb; 147(2):204-11. PubMed ID: 19878963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoma of the gastric cardia.
    Hölscher AH; Bollschweiler E; Siewert JR
    Ann Chir Gynaecol; 1995; 84(2):185-92. PubMed ID: 7574379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.
    Borch K; Jönsson B; Tarpila E; Franzén T; Berglund J; Kullman E; Franzén L
    Br J Surg; 2000 May; 87(5):618-26. PubMed ID: 10792320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma.
    Michelassi F; Takanishi DM; Pantalone D; Hart J; Chappell R; Block GE
    Surgery; 1994 Oct; 116(4):804-9; discussion 809-10. PubMed ID: 7940182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
    Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
    J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivariate analysis by Cox Proportional Hazards Model on prognoses of patients with bile duct carcinoma after resection.
    He P; Shi J; Chen W; Wang Z
    Chin Med J (Engl); 2002 Oct; 115(10):1538-41. PubMed ID: 12490105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on factors influencing survival in patients with cancer of the esophagus after resection by Cox proportional hazard model].
    Zhang H; Ping Y; Du X
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):32-4. PubMed ID: 11776792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of survival time after curative surgery for advanced gastric cancer.
    Moriguchi S; Maehara Y; Korenaga D; Sugimachi K; Hayashi Y; Nose Y
    Eur J Surg Oncol; 1992 Jun; 18(3):287-92. PubMed ID: 1607042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multi-variate analysis of prognostic factors in gastric cancer with Cox' proportional hazard model].
    Nakajima T; Ota K; Ishihara S; Wakabayashi K; Nishi M
    Gan To Kagaku Ryoho; 1994 Aug; 21(11):1768-74. PubMed ID: 8080294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of tumor invasion and lymph node involvement on the prognosis and selection for surgery of adenocarcinoma of the cardia.
    Ponsioen CY; Welvaart K; Hermans J
    Eur J Surg Oncol; 1989 Aug; 15(4):301-6. PubMed ID: 2759248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
    Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
    Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognosis of gastric cardia cancer after R0 resection.
    An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Am J Surg; 2010 Jun; 199(6):725-9. PubMed ID: 19837398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival analysis after surgical treatment of gastric cancer: review of 121 cases.
    Nazli O; Derici H; Tansug T; Yaman I; Bozdag AD; Isgüder AS; Bölükbasi H
    Hepatogastroenterology; 2007 Mar; 54(74):625-9. PubMed ID: 17523337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.